Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccine

K Yato, M Matsuda, N Watanabe, K Watashi, H Aizaki… - Antiviral Research, 2022 - Elsevier
Direct-acting antivirals (DAAs) have been introduced for the treatment of hepatitis C virus
(HCV); however, there is still no available vaccine for preventing HCV infection. We …